financetom
Business
financetom
/
Business
/
Ciena's Fiscal Q1 Adjusted Earnings Rise While Revenue Drops -- Shares Slump Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ciena's Fiscal Q1 Adjusted Earnings Rise While Revenue Drops -- Shares Slump Pre-Bell
Mar 7, 2024 5:24 AM

07:46 AM EST, 03/07/2024 (MT Newswires) -- Ciena (CIEN) reported fiscal Q1 adjusted net income Thursday of $0.66 per diluted share, up from $0.64 a year earlier.

Analysts polled by Capital IQ expected $0.48.

Revenue for the fiscal quarter ended Jan. 27 was $1.04 billion, down from $1.06 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.02 billion.

Ciena shares were down 12% in recent Thursday premarket activity.

Price: 54.5, Change: -7.46, Percent Change: -12.04

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Myers Industries Names Samantha Rutty as CFO
Myers Industries Names Samantha Rutty as CFO
Sep 5, 2025
08:23 AM EDT, 09/05/2025 (MT Newswires) -- Myers Industries ( MYE ) said Friday it appointed Samantha Rutty as chief financial officer, starting Sept. 22. Rutty will succeed Daniel Hoehn, who has been interim CFO since May 2 and will continue to work as vice president and corporate controller after the transition, the company said. Rutty will join Myers Industries...
Theratechnologies Launches New Tesamorelin Formulation in US After FDA Approval
Theratechnologies Launches New Tesamorelin Formulation in US After FDA Approval
Sep 5, 2025
08:23 AM EDT, 09/05/2025 (MT Newswires) -- Theratechnologies ( THTX ) said Friday its new tesamorelin formulation, Egrifta WR, is now available following Food and Drug Administration approval earlier this year. The drug is used to reduce excess abdominal fat in adult patients with HIV and lipodystrophy. The new version will gradually replace Egrifta SV. Egrifta WR requires weekly reconstitution...
BBVA Gets Approval for $20.3 Billion Banco Sabadell Takeover; Shareholders' Offer Opens Sept. 8
BBVA Gets Approval for $20.3 Billion Banco Sabadell Takeover; Shareholders' Offer Opens Sept. 8
Sep 5, 2025
08:25 AM EDT, 09/05/2025 (MT Newswires) -- Banco Bilbao Vizcaya Argentaria ( BBVA ) said Friday the Spanish National Securities Market Commission has approved its move to acquire Banco Sabadell in a deal valued at 17.40 billion Euros ($20.30 billion) and the take-up period is scheduled to begin on Sept. 8 for Banco Sabadell shareholders to accept its proposal. The...
Samsara Overcomes Q1 Tariff Woes, Poised for Growth on Deals Momentum, RBC Says; Shares Up Pre-Bell
Samsara Overcomes Q1 Tariff Woes, Poised for Growth on Deals Momentum, RBC Says; Shares Up Pre-Bell
Sep 5, 2025
08:21 AM EDT, 09/05/2025 (MT Newswires) -- Samsara (IOT) strong Q2 results show that the Internet-of-Things sensor developer has overcome Q1 tariff pressures and is poised for further growth, RBC said in a note to investors Thursday. The note described large deal momentum among six- and seven-figure customers, improving international business as well as its deal with Bonnie Plants, its...
Copyright 2023-2026 - www.financetom.com All Rights Reserved